TriangleNCT02574455 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- other Details
- After study conclusion and without prior written approval from Immunomedics and Gilead sciences, investigators in this study may communicate, orally present/publish in scientific journals/other media only after following conditions have been met: * The results of the study in their entirety have been publicly disclosed by or with the consent of Immunomedics and Gilead sciences in an abstract, manuscript/presentation form; or * The study has been completed at all study sites for at least 2 years
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- GileadClinicalTrials@gilead.com
- organization
- Gilead Sciences
- phone
- 1-833-445-3230 (GILEAD-0)
- title
- Gilead Clinical Study Information Center
Complete source fields
- certain Agreement
- other Details
- After study conclusion and without prior written approval from Immunomedics and Gilead sciences, investigators in this study may communicate, orally present/publish in scientific journals/other media only after following conditions have been met: * The results of the study in their entirety have been publicly disclosed by or with the consent of Immunomedics and Gilead sciences in an abstract, manuscript/presentation form; or * The study has been completed at all study sites for at least 2 years
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- GileadClinicalTrials@gilead.com
- organization
- Gilead Sciences
- phone
- 1-833-445-3230 (GILEAD-0)
- title
- Gilead Clinical Study Information Center
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice